InsidersTradesSigma
Follow the Ocumension Therapeutics - B share price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Ocumension Therapeutics - B has logged 6 reports. Market capitalisation: €4.1bn. The latest transaction was reported on 3 July 2026 (Sale). Among the most active insiders: Hu Zhaopeng. Every trade is accessible without an account.
6
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ocumension Therapeutics - B Buy (bullish), based on 2 analysts. Average price target: HK$9.59.
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,902 of 29,062 companies
26.2
score / 100
Value20
Quality32
FCF yld-8.6%
Earn yld-3.8%
EV/EBITDA·
ROE-3.4%
Gross mgn45%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations6 total
742 sharesShareXHKGHKEX:DA20260702E00734
2,700 sharesShareXHKGHKEX:DA20260702E00733
13,700 sharesShareXHKGHKEX:DA20260618E00004
1,648 sharesShareXHKGHKEX:DA20260618E00003
140,000 sharesShareXHKGHKEX:DA20260618E00002
6 of 6 declarations
About Ocumension Therapeutics - B
Ocumension Therapeutics - B is a company focused on developing ophthalmic treatments. It emphasizes innovation in the healthcare and pharmaceutical sectors.